Know Labs, Inc. announced it has been selected for an oral abstract presentation at the American Association of Clinical Endocrinology (AACE) Annual Meeting in New Orleans, Louisiana on May 9, 2024 from 11:15 a.m. - 11:30 a.m. CDT. The Company will present an abstract titled, "Efficacy of a Non-Invasive Blood Glucose Monitor for Diabetes Management Using a Radiofrequency Sensor and Machine Learning." Know Labs first announced these interim results in March of this year from its clinical research protocol involving people with diabetes, using intravenous blood as a comparative reference and a machine learning model trained on data collected in a lab setting. During 2024, as the Company continues on the path toward FDA clearance, Know Labs will deploy the KnowU??, its wearable, non-invasive continuous glucose monitor (CGM) in large-scale, external clinical trials while advancing model techniques and making refinements to the device.

These new studies will help determine the technology's performance throughout continuous wear, in more real-world environments, and within more extreme glycemic ranges (below 70 mg/dL and above 350 mg/dL).